BioPharma makes investment in Insmed for disease therapy development
(Alliance News) - BioPharma Credit PLC on Thursday said it has made a USD140.0 million investment in US biopharmaceutical company Insmed Inc for the development of therapies to treat neutrophil-mediated inflammatory diseases and rare pulmonary disorders.
Read more